Objective. To determine the frequency of pericardial and pleural effusions in scleroderma. Methods. Using a case-control format, patients with scleroderma and no known cardiac disease were recruited. Echocardiograms and chest radiographs were performed. Age-and gender-matched controls had echocardiograms performed which were read by a cardiologist, blinded to the diagnosis. The medical records of 60 other scleroderma patients were also reviewed.
S is a connective tissue disease causing ation of scleroderma [4] . Unfortunately, the case histories of these patients were not given. Pericarditis is a fibrosis of the skin and visceral organs such as the lungs, gastrointestinal tract and heart [1] . There are common manifestation in lupus, and occurs in 15-50% [5] . The prevalence of pericardial effusions in rheumatwo main variants: limited scleroderma and diffuse scleroderma. Limited scleroderma has been defined as toid arthritis ranges between 30 and 50% [6] [7] [8] .
We decided to study patients with scleroderma and skin involvement distal to the elbows or knees with or without involvement of the face. Diffuse scleroderma controls to determine the frequency of pleural and pericardial effusions. involves sclerodermatous skin changes proximal to the elbows or knees [2] .
Some less common features of scleroderma, such as PATIENTS AND METHODS the frequency of pleural and pericardial effusions, have
The study was approved by our ethics committee. been reported but not systematically described. We
Informed consent was obtained. Thirty-seven patients noticed two patients with scleroderma, and no other with diffuse or limited scleroderma who met the manifestations of other connective tissue disease, who American Rheumatism Association (ARA) preliminhave had significant pleural and/or pericardial effuary criteria for scleroderma were recruited from an sions. These effusions occurred in the absence of any out-patient population in Southwestern Ontario [9] . A obvious interstitial lung disease or congestive heart group of 37 controls matched for age and sex were failure and were found to be exudative. Previous recruited for the echocardiographic portion of the literature discloses very little information as to why study. The controls were obtained from friends of the patients with scleroderma have pericardial or pleural scleroderma subjects and from an out-patient rheumaeffusions. Furthermore, the literature reports pleural tology practice. The controls were excluded if they had effusions only rarely in scleroderma [3] . It is unknown scleroderma or systemic lupus erythematosus (SLE). whether an autoimmune serositis is the aetiology of Subjects and controls were randomly assigned a twothese rare isolated pleural effusions as opposed to digit identification number for the purpose of blinding pleural fibrosis. throughout the study. As for pericardial effusions, a study of 44 post Each patient underwent a standardized history and mortem samples in scleroderma revealed 31 cases with physical examination. The history was composed of chronic pericarditis and 37.5% of the cases showed questions directly related to the signs and symptoms myocardial fibrosis. It was thought that the pericarditis of scleroderma, such as skin pigment change, digital was not due to uraemia and was a primary manifestulceration, alopecia, joint involvement, bowel habits and general health. Specific questions directed at the symptoms of congestive heart failure and pulmonary ence of pleural and pericardial effusions, and for signs of congestive heart failure or interstitial lung disease. When comparing cases and controls and those with obtained from the out-patient rheumatology practice who were age and gender matched. These included diffuse and limited disease, descriptive statistics and t-tests or x2 tests were performed. two with vasculitis (no known cardiac involvement), three with rheumatoid arthritis (RA) (and no known We also reviewed charts of 60 out-patients with scleroderma at our centre (who did not participate in serositis), one with a neuropathy, three with inflammatory arthritis (seronegative) and two with fibrothe above study) to help estimate frequencies of pleural and pericardial effusions in those who had previously myalgia. None of the controls had lupus. In the 37 scleroderma subjects, only one patient was documented echocardiograms and chest radiographs.
found to have a pleural effusion on the routine PA RESULTS and lateral chest radiograph. This patient was a 44-yrold woman with a 6 yr history of diffuse scleroderma. The scleroderma patients recruited for our prospective study consisted of 33 women and four men with a
The patient had no findings consistent with pneumonia or congestive heart failure, and no evidence of pulmean age of 53.9 yr and a range of 27-73 yr. Eighteen of the 37 patients were classified as having diffuse monary pathology such as interstitial fibrosis. Three patients, all with diffuse disease, had changes which scleroderma and the remaining 19 were diagnosed with limited scleroderma. The mean disease duration was were compatible with interstitial fibrosis. Two of 37 study patients were discovered to have 7.5 yr (median 4 yr, range 1-24 yr). Thirty-six patients had Raynaud's and 35 complained of oesophageal pericardial effusions on echocardiogram reported as mild to moderate in size. The first subject was the symptoms. Twelve had some symptoms of small bowel overgrowth or other non-oesophageal bowel involve-44-yr-old woman described above. This patient also showed mild mitral regurgitation, mild tricuspid regurment. Seven patients had lung disease (with crackles heard on chest auscultation). Two had known pulmongitation, pulmonary hypertension and the presence of a moderate pericardial effusion. The second subject ary hypertension from long-standing scleroderma, whereas one had cardiomegaly on chest radiograph at was a 65-yr-old woman with a 2 yr history of diffuse scleroderma. This subject had an otherwise normal the time of scleroderma diagnosis thought to be due to hypertension. Those with limited disease were echocardiogram with the exception of some mild aortic sclerosis. There were no pericardial effusions detected slightly older than those with diffuse disease. None had symptoms of congestive heart failure. The mean in the control group and in fact 20 controls had normal echocardiograms compared to only 13 in the scleroblood pressure was normal. Patients with diffuse disease had lower grip strengths, higher skin scores and derma group. Table II summarizes the results of the echocardiograms. worse global assessments than those with limited disease. Table I summarizes the demographic information In our chart review of 60 scleroderma patients, 21 were discovered to have previously documented chest of the prospective study participants. A group of 37 controls (33 women and four men) matched for age radiographs, eight of whom had limited scleroderma and 13 with diffuse disease. In the patients with limited (± 5 yr) and sex were recruited. Most controls were healthy subjects who accompanied the cases for their scleroderma, six of the chest radiographs were normal, one patient had pulmonary fibrosis and one patient appointment. However, the remaining controls were Patients  18  19  37  37  Pericardial effusions  2  0  2  0  Pulmonary hypertension  3  0  3  3  Aortic regurgitation  1  2  3  2  Mitral regurgitation  3  7  10  8  Tricuspid regurgitation  2  6  8  10  Pulmonary regurgitation  1  0  1  2  Aortic sclerosis  4  2  6  5  Normal echocardiogram  8  5  13 20* *P = 0.1.
had a pleural effusion with no evidence of congestive as 21% [16 ], 25% [17] and 29% [18] with sample sizes of 11, 14 and 20, respectively. Of the 18 patients with heart failure. In the patients with diffuse disease, nine were normal, two of 13 were found to have pleural diffuse scleroderma in our blinded case-control study, only two (11.1%) were detected with pericardial effueffusions, one had interstitial lung disease, and one patient was a heavy smoker with evidence of chronic sions. Therefore, it would seem that we found the prevalence of pericardial effusions in our scleroderma obstructive pulmonary disease.
Only nine of the 60 patients had echocardiograms population to be somewhat lower than previously reported. We also excluded patients with an overlap documented. Five patients with diffuse disease revealed two normal echocardiograms, one with pulmonary between scleroderma and other connective tissue diseases such as SLE and RA, and used only out-patients hypertension and two with pericardial effusions. Four patients with limited scleroderma had echocardioin our study. This may have eliminated an association of pericardial effusions with more ill scleroderma grams, of which two were normal, one patient had a pericardial effusion and left atrial enlargement, and patients or those with serositis from an overlap disease. When compiling our case-control study data with our one had evidence of trivial aortic and mitral insufficiency. chart review, 17% of patients with diffuse scleroderma were found to have pericardial effusions, which is DISCUSSION slightly less than, but in keeping with, previous literature [16] [17] [18] . Pleural effusions are uncommon in scleroderma [3, [11] [12] [13] [14] in the absence of clinical congestive heart failure Our study is small, but blinding the echocardiographer enhanced the results. From our subjects, it can or interstitial lung disease, but have been reported in 15% of patients with an overlap syndrome and sclerobe determined that pericardial effusions are uncommon but more frequent in diffuse scleroderma. A larger derma [15] . However, we observed a few patients in our scleroderma population with significant pleural study may confirm that pericardial effusions are very rare in limited scleroderma. Chest radiographs of scleroeffusions that were not explained by other aetiologies. We hypothesized that pleural effusions may actually derma patients rarely show evidence of pleural effusions. In the absence of congestive heart failure, and be more common than reported by previous literature and may be more prevalent in patients with diffuse with other scleroderma patients demonstrating an exudative process, the effusions may be from an initial compared to limited disease. Upon testing this hypothesis, and excluding the index cases, our prospective inflammatory reaction followed by fibrosis. case-control study found the presence of a pleural A effusion in only one out of the 37 study patients, which
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Health Sciences Center, London, ON N6A 4G5, Our chart review provided three additional pleural Canada. effusions in 21 patients with chest radiographs and thus 7% (4/58) of patients in our cohort had pleural R effusions and this was more frequent in diffuse disease.
